Organization
Ospedali Galliera
4 clinical trials
Clinical trial
A Randomized, Phase II, Double-blind, Placebo-controlled, Multicenter, 2x2 Factorial Design Biomarker Tertiary Prevention Trial of Low-dose Aspirin and Metformin in Stage I-III Colorectal Cancer Patients. The ASAMET TrialStatus: Active (not recruiting), Estimated PCD: 2024-03-31
Clinical trial
EXemestane in Progesterone and/or Estrogen Receptor Positive Epithelial Ovarian Cancer: A Randomized Phase III Trial, EXPERTStatus: Terminated, Estimated PCD: 2023-04-27
Clinical trial
Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer: a Randomized Phase III Trial (LEPRE Trial)Status: Recruiting, Estimated PCD: 2029-09-22
Clinical trial
Ferrochelating Treatment in Patients Affected by "Neurodegeneration With Brain Iron Accumulation" (NBIA)Status: Active (not recruiting), Estimated PCD: 2024-12-01